N, N-Dipropyldopamine (hydrobromide)
N. N-dipropyrldopamine is a potent inhibitor of glutamate release and has anticancer activity. The increase of glutamate secretion leads to cancer-induced bone pain (CIBP) . N. N-dipropyrldopamine plays an analgesic role in CIBP[1].
Product Specifications
CAS Number
[65273-66-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MGluR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/n-n-dipropyldopamine-hydrobromide.html
Purity
98.22
Solubility
10 mM in DMSO
Smiles
OC1=CC=C(CCN(CCC)CCC)C=C1O.[H]Br
Molecular Formula
C14H24BrNO2
Molecular Weight
318.25
Precautions
H302, H315, H319, H335
References & Citations
[1]Fazzari J, et al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
